Invitae | Proactive health screens

Proactive testing

Genetic tests for healthy adults who want to understand their DNA and focus on prevention

Order now

Empower your practice with proactive genetic testing

Proactive genetic testing offers healthy adults without a strong personal or family history of disease an opportunity to learn about how their genes could potentially impact their health.
Invitae offers three testing options that analyze up to 139 genes that are well-established indicators of a significantly increased risk of developing hereditary cancers, cardiovascular conditions, and other medically important disorders.
If your patient receives a positive test result, their first-degree family members may get tested at no additional charge.
Our diagnostic-grade tests are performed in a CLIA- and CAP-certified laboratory and reviewed by our team of Ph.D. scientists, lab directors, and board-certified genetic counselors.

1. Haverfield E. Multigene panel screening for hereditary disease risk in healthy individuals. Poster presented at: ACMG Annual Meeting; April 12, 2018; Charlotte, NC.

Is proactive testing right for my patient?

Proactive testing is right for patients with no personal or family medical history of cancer or cardiovascular conditions. For instances where the test choice is unclear, the following tool can help.

CHOOSING THE RIGHT TEST

Still have questions? Invitae's Clinical Consult team is available on-demand to discuss individual cases, including whether proactive testing might be appropriate for your patient.

Choose your proactive test

Invitae offers three test options so you can select the type of information you want to receive.

Invitae cancer screen Analyzes 57 genes Invitae cardio screen Analyzes 75 genes Invitae genetic health screen Analyzes 139 genes Conditions tested for include:
	Invitae cancer screen Analyzes 57 genes Conditions tested for include:	Invitae cardio screen Analyzes 75 genes Conditions tested for include:	Invitae genetic health screen Analyzes 139 genes Conditions tested for include:
Aortopathies
Arrhythmias
Breast cancer
Cardiomyopathies
Colorectal cancer
Cutaneous melanoma
Gastric cancer
Genetic forms of high blood pressure and high cholesterol
Ovarian cancer
Pancreatic cancer
Prostate cancer
Renal cell cancer
Thrombophilia
Thyroid cancer
Additional conditions
Alpha-1 antitrypsin deficiency
Hereditary hemochromatosis
Malignant hyperthermia susceptibility
	$250*	$250*	$475*

For details on the genes tested, view our full gene list.

*Invitae does not support insurance billing for proactive testing. Be sure to include your patient's email address on the test requisition for payment and test registration.

How it works

Due to the potential health implications of this test, Invitae proactive tests must be ordered by a healthcare provider on behalf of their patients.

Complete and return the test requisition and consent form. Make sure to include an email address for you or your practice, so we can create your online clinician portal account. You can use this account to track the progress of your patient's sample and receive results.

Request a free blood or saliva collection kit to collect your patient's specimen.

You will receive an email notification once we receive the specimen and another when the results are ready, typically 10 to 21 days after the sample is received.

If you or your patient have questions about the results, Invitae offers clinical support services at no additional charge.

Know the potential results

Positive	If your patient receives a positive (pathogenic or likely pathogenic) test result, this means that the test found a clinically significant genetic change that increases their risk of developing a specific medical condition. The Invitae proactive tests do not report variants of uncertain significance (VUS), but may report carrier status.
Negative	If your patient receives a negative test result, this means that they do not carry genetic changes in the genes evaluated that are currently known to be associated with serious health conditions.